Resources

The I-Study is a healthcare industry calibration study on genomic interpretation with the goal of helping to accelerate the advancement of personalized medicine and related scientific discovery into day-to-day clinical healthcare practice.

My Personal Exome, Courtesy or 23andMe By Francisco M. De La Vega After months of anxious waiting, I finally received my exome data from the 23andMe Exome Pilot about a week ago. When I enrolled last year – 23andMe

The Elusive Appeal of Exome Sequencing In the past few years, the prices of sequencing have plummeted and now for a few thousand dollars, the complete sequence of an individual can be obtained. Even so, many scientists have opted to

November 22, 2011 Janine Holley The opening plenary session of the International Congress of Human Genetics, held in Montreal last October, featured a dazzling display by Cirque Eloize followed by a 90 minute panel discussion on the subject of

Bio IT World has just published a comprehensive market study on the future of next gen sequencing and to give us her perspective on the report, which you can download for free. In addition, please join the discussion and add

Mary Ann Brown (Cambridge Healthtech Institute) met up with three of the scheduled speakers for the upcoming NG(x) Applying Next Generation Sequencing and Next Generation Sequencing Data Management meetings. She asked them each to describe their experiences with next

With lower costs for next-generation sequencing (NGS) come dramatic
surges in data volume. As a result, there are myriad software solutions
for annotating, analyzing and interpreting the data. This March 1, 2011
clinic explored the chief advantages and applications of each software
system.

A report describing current innovations in next-gen sequencing and their impact on
the
market sector. The report reviews the history and evolution of NGS and provides an analysis of systems on
the market today, a glimpse at those on the horizon, innovations still in R&D,
and NGS market dynamics.

This paper focuses on digital imaging data, which is perhaps the most
varied of all rich data and remains the most widely used in drug
discovery and development. Importantly, the issues around managing
digital images reflect rich data management challenges generally.

Video of a panel discussion that originally took place March 18, 2011 at X GEN Congress in San Diego. Esteemed panelists from AltheaDx, Illumina, Scientia Advisors, Kaiser Permanente, and U of Iowa discussed clinical applications of whole genome sequencing.

Thirteen years ago, a beer summit in an English pub spawned the birth of Solexa and the world’s leading next generation sequencing technology. In this article, Kevin Davies looks back on the key players and how they came together to form Solexa, tracking the company's growth from inception to its position today.

NGS has generated a great deal of excitement in the life sciences research community in recent years. Funding agencies have focused on genomics in general and NGS in particular, resulting in rapid dissemination of high-throughput, short-read instruments and chemistries. The bioinformatics community has cooperated by providing continually improved means to deal with the mounds of data rolling out from genome labs and centers. In the Next-Generation Sequencing Technologies: Applications and Markets report, we examine the broad spectrum of NGS applications used in studies, which even at this early date have already begun delivering intriguing new insights in a variety of fields.

Next Generation Genetics and Biopharma Will sequencing prove the Beginning of the End, or the End of the Beginning for biopharma? By Alexander Kamb. Even for a jaundiced veteran of the biopharmaceutical industry, it’s hard not to gush over the astounding output

In December 2008, Cambridge Healthtech Institute conducted an online survey of next generation sequencing user practices and views. Results are reported herein for two segments academic and industrial users. Among industrial respondents, eight were current next generation users and two